Rheumatology Medical News about adiposity;under-recognized risk factor;tendonopathy

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Is adiposity an under-recognized risk factor for tendinopathy? A systematic review
Arthritis Care and Research , 06/03/09

Gaida JE et al. – Review of observational studies suggest that elevated adiposity is a risk factor for tendon injury, although this association appears to vary depending on aspects of study design and measurement. Further research would determine if reducing adiposity will reduce the risk of tendon injury or improve the results of treatment.

Methods

Aim was to examine the extent and consistency of associations between adiposity and tendinopathy
8 electronic databases were searched:
- Allied and Complementary Medicine
- Biological Abstracts, CINAHL, Current Contents,
- EMBase, Medline, SPORTDiscus, and Web of Science
  and citation tracking was performed on included reports
Studies were included if:
- they compared adiposity between subjects with and w/o tendon injury or
- examined adiposity as a predictor of conservative treatment success

Results

4 longitudinal cohorts, 14 cross-sectional studies, 8 case-control studies, and 2 interventional studies (28 in total) met the inclusion criteria providing a total of 19,949 individuals
18/42 (43%) subpopulations showed elevated adiposity to be associated with tendon injury
Sensitivity analyses: a clustering of positive findings among studies that included clinical pts (81% positive) and among case-control studies (77% positive)

<< Previous
Anti-hnRNP and other autoantibodies in systemic sclerosis with...

Next >>
How to perform local soft-tissue glucocorticoid injections